Enrichment technique to allow early detection and monitor emergence of KRAS mutation in response to treatment
Abstract Sensitivity of cell-free circulating tumour DNA (ctDNA) assays is often hampered by the limited quantity of intact mutant nucleotide fragments. To overcome the issue of substrate limitation in clinical applications, we developed an enrichment method utilizing pyrrole-imidazole (PI) polyamid...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2019
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/2053aba583244414bcf40be73b7b6ae7 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:2053aba583244414bcf40be73b7b6ae7 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:2053aba583244414bcf40be73b7b6ae72021-12-02T15:08:58ZEnrichment technique to allow early detection and monitor emergence of KRAS mutation in response to treatment10.1038/s41598-019-47700-92045-2322https://doaj.org/article/2053aba583244414bcf40be73b7b6ae72019-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-019-47700-9https://doaj.org/toc/2045-2322Abstract Sensitivity of cell-free circulating tumour DNA (ctDNA) assays is often hampered by the limited quantity of intact mutant nucleotide fragments. To overcome the issue of substrate limitation in clinical applications, we developed an enrichment method utilizing pyrrole-imidazole (PI) polyamides and their ability to bind the minor groove of B-DNA. We present here a proof-of-concept experiment to enrich specific mutant KRAS alleles with biotinylated PI polyamides. We investigated the clinical feasibility of incorporating PI polyamides to detect KRAS mutations in ctDNA from 40 colorectal cancer (CRC) patients, of whom 17 carried mutations in KRAS. After enriching ctDNA with those polyamides, we used digital PCR to detect several common KRAS codon 12 mutations. Enrichment by biotinylated PI polyamides improved the sensitivity of ctDNA analysis (88.9% vs. 11.1%, P < 0.01) in 9 non-metastatic mutation-positive patients. We observed no differences in performance for the 8 metastatic subjects (100% vs. 75%, P = 0.47). In the remaining 23/40 patients with wild type KRAS codon 12, no mutant alleles were detected with or without polyamide-facilitated enrichment. Enriching B-form of ctDNA with PI polyamides significantly improved the assay sensitivity in detecting KRAS mutations in non-metastatic CRC patient samples.Yoshiyasu KitagawaKazuhiro OkumuraTakayoshi WatanabeKei TsukamotoShiro KitanoRino NankinzanTakuto SuzukiTaro HaraHiroaki SodaTadamichi DendaTaketo YamaguchiHiroki NagaseNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 9, Iss 1, Pp 1-9 (2019) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Yoshiyasu Kitagawa Kazuhiro Okumura Takayoshi Watanabe Kei Tsukamoto Shiro Kitano Rino Nankinzan Takuto Suzuki Taro Hara Hiroaki Soda Tadamichi Denda Taketo Yamaguchi Hiroki Nagase Enrichment technique to allow early detection and monitor emergence of KRAS mutation in response to treatment |
| description |
Abstract Sensitivity of cell-free circulating tumour DNA (ctDNA) assays is often hampered by the limited quantity of intact mutant nucleotide fragments. To overcome the issue of substrate limitation in clinical applications, we developed an enrichment method utilizing pyrrole-imidazole (PI) polyamides and their ability to bind the minor groove of B-DNA. We present here a proof-of-concept experiment to enrich specific mutant KRAS alleles with biotinylated PI polyamides. We investigated the clinical feasibility of incorporating PI polyamides to detect KRAS mutations in ctDNA from 40 colorectal cancer (CRC) patients, of whom 17 carried mutations in KRAS. After enriching ctDNA with those polyamides, we used digital PCR to detect several common KRAS codon 12 mutations. Enrichment by biotinylated PI polyamides improved the sensitivity of ctDNA analysis (88.9% vs. 11.1%, P < 0.01) in 9 non-metastatic mutation-positive patients. We observed no differences in performance for the 8 metastatic subjects (100% vs. 75%, P = 0.47). In the remaining 23/40 patients with wild type KRAS codon 12, no mutant alleles were detected with or without polyamide-facilitated enrichment. Enriching B-form of ctDNA with PI polyamides significantly improved the assay sensitivity in detecting KRAS mutations in non-metastatic CRC patient samples. |
| format |
article |
| author |
Yoshiyasu Kitagawa Kazuhiro Okumura Takayoshi Watanabe Kei Tsukamoto Shiro Kitano Rino Nankinzan Takuto Suzuki Taro Hara Hiroaki Soda Tadamichi Denda Taketo Yamaguchi Hiroki Nagase |
| author_facet |
Yoshiyasu Kitagawa Kazuhiro Okumura Takayoshi Watanabe Kei Tsukamoto Shiro Kitano Rino Nankinzan Takuto Suzuki Taro Hara Hiroaki Soda Tadamichi Denda Taketo Yamaguchi Hiroki Nagase |
| author_sort |
Yoshiyasu Kitagawa |
| title |
Enrichment technique to allow early detection and monitor emergence of KRAS mutation in response to treatment |
| title_short |
Enrichment technique to allow early detection and monitor emergence of KRAS mutation in response to treatment |
| title_full |
Enrichment technique to allow early detection and monitor emergence of KRAS mutation in response to treatment |
| title_fullStr |
Enrichment technique to allow early detection and monitor emergence of KRAS mutation in response to treatment |
| title_full_unstemmed |
Enrichment technique to allow early detection and monitor emergence of KRAS mutation in response to treatment |
| title_sort |
enrichment technique to allow early detection and monitor emergence of kras mutation in response to treatment |
| publisher |
Nature Portfolio |
| publishDate |
2019 |
| url |
https://doaj.org/article/2053aba583244414bcf40be73b7b6ae7 |
| work_keys_str_mv |
AT yoshiyasukitagawa enrichmenttechniquetoallowearlydetectionandmonitoremergenceofkrasmutationinresponsetotreatment AT kazuhirookumura enrichmenttechniquetoallowearlydetectionandmonitoremergenceofkrasmutationinresponsetotreatment AT takayoshiwatanabe enrichmenttechniquetoallowearlydetectionandmonitoremergenceofkrasmutationinresponsetotreatment AT keitsukamoto enrichmenttechniquetoallowearlydetectionandmonitoremergenceofkrasmutationinresponsetotreatment AT shirokitano enrichmenttechniquetoallowearlydetectionandmonitoremergenceofkrasmutationinresponsetotreatment AT rinonankinzan enrichmenttechniquetoallowearlydetectionandmonitoremergenceofkrasmutationinresponsetotreatment AT takutosuzuki enrichmenttechniquetoallowearlydetectionandmonitoremergenceofkrasmutationinresponsetotreatment AT tarohara enrichmenttechniquetoallowearlydetectionandmonitoremergenceofkrasmutationinresponsetotreatment AT hiroakisoda enrichmenttechniquetoallowearlydetectionandmonitoremergenceofkrasmutationinresponsetotreatment AT tadamichidenda enrichmenttechniquetoallowearlydetectionandmonitoremergenceofkrasmutationinresponsetotreatment AT taketoyamaguchi enrichmenttechniquetoallowearlydetectionandmonitoremergenceofkrasmutationinresponsetotreatment AT hirokinagase enrichmenttechniquetoallowearlydetectionandmonitoremergenceofkrasmutationinresponsetotreatment |
| _version_ |
1718387925346942976 |